Posters and publications

Oral Superabsorbent Hydrogel Expands Akkermansia and Drives Changes to the Gut Microbiota Associated with Metabolic Benefits in a Mouse Model of Diet Induced Obesity

Gut Microbiota Contributes to the Beneficial Metabolic Effects of Gelesis Hydrogel Technology

Oral administration of Gelesis200 significantly decreases body weight in people with prediabetes or type 2 diabetes with overweight or obesity: results of the LIGHT-UP study

Safety and tolerability of Gelesis200 in the management of overweight and obesity in people with prediabetes or type 2 diabetes: comprehensive analysis of the LIGHT-UP study

Oral Superabsorbent Hydrogel Expands Akkermansia and Drives Changes to the Gut Microbiota Associated with Metabolic Benefits in a Mouse Model of Diet Induced Obesity

Unique Physical Properties of an Oral Super Absorbent Hydrogel Compared to Common Fiber Supplements

Plenity® Treatment In The Gelesis Loss of Weight (GLOW) Study Was Associated With Improvement In Liver Health, As Measured By The NAFLD Fibrosis Score

Impaired β-cell Function is Associated with Evidence of Dysfunctional Gut Barrier

Evaluating Glucose and Insulin as Predictors of Weight Loss in GLOW: A Novel Statistical Approach

Evaluating the Interaction of an Oral Superabsorbent Hydrogel with Alcohol and Acidic Beverages

Comprehensive analysis of safety and tolerability of Gelesis100 in overweight and obesity in the pivotal GLOW study

Assessment of the safety and tolerability of Gelesis100 in the pivotal GLOW study

Comprehensive analysis of safety and tolerability of Gelesis100 in overweight and obesity in the pivotal GLOW study

Assessment of the safety and tolerability of Gelesis100 in subjects who reached a body mass index below 27 kg/m2in the pivotal GLOW study

GS300 Novel, Non-Systemic, Superabsorbent Hydrogel Improves Intestinal Barrier Function in Intestinal Injury Pre-Clinical Model

Explore the clinical research supporting Plenity®

Learn more